Fonden for scleroseramte paa Fyn Report issue

Foundation

Organization Overview

First Clinical Trial
2018
NCT03847545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Fonden for scleroseramte paa Fyn

Active Ingredients

Drugs in Other Trials (1)

4-aminopyridine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1